Breast Cancer Survivor Story | Sheryl at Immunocine Cancer Center

"When we started this process, I never expected to have such a committed, caring, and attentive team. People need to know this exists and it can save a lot lives." - Sheryl H

First diagnosed with Breast Cancer in 2012, Sheryl thought she had achieved remission after receiving Chemotherapy and Radiation. In 2022, Sheryl's cancer relapsed and she was diagnosed with Stage 4 Breast Cancer with metastases to her femur. Not content with a prognosis of 18 months, Sheryl began looking for alternative cancer treatment centers.

After extensive research into the latest developments in Cancer Research, Sheryl and her daughter decided to pursue Immunocine's Cancer Immunotherapy. Receiving treatment in April 2022, Sheryl felt her Immune System attacking her once unresponsive tumor in her femur. By August 2022, her physicians in Canada confirmed that the tumor in her femur had been eliminated.

As one of Immunocine's first patients, Sheryl wanted to share her story with other cancer patients seeking an alternative to their late-stage cancer.

----------------------------------------------------------------
Interested in exploring Immunocine's revolutionary Cancer Treatment? Learn more at https://immunocine.com/
----------------------------------------------------------------

The Immunocine Cancer Center provides one of the most advanced Cancer Immunotherapies available. Backed by research and multiple clinical trials, the Immunocine Treatment is meant for the cancer patients of today seeking the cancer treatment of tomorrow.